Prevalence of frailty in patients with non-cirrhotic non-alcoholic fatty liver disease.
Naimimohasses S, O'Gorman P, McCormick E, Ferguson D, Monaghan A, McGrath M, Robinson MW, Gormley J, Norris S.
Naimimohasses S, et al.
BMJ Open Gastroenterol. 2022 May;9(1):e000861. doi: 10.1136/bmjgast-2021-000861.
BMJ Open Gastroenterol. 2022.
PMID: 35523460
Free PMC article.
Using the SRFI, 45% of F0/F1 patients were classified as prefrail and 20% were classified as frail, while in F2/F3 patients this increased to 36% and 41%, respectively. SRFI, 30 s sit-to-stand and FI-LAB scores increased with increasing liver fibrosis stages (p=0.001, 0.00 …
Using the SRFI, 45% of F0/F1 patients were classified as prefrail and 20% were classified as frail, while in F2/F3 patients this increased t …